« Back to Record
Di Leo, A., Larsimont, D., Gancberg, D., Järvinen, T., Beauduin, M., Vindevoghel, A., Michel, J., Focan, C., Ries, F., Gobert, P. H., Closon-Dejardin, M. T., Dolci, S., Rouas, G., Paesmans, M., Lobelle, J. P., Isola, J., & Piccart-Gebhart, M. (2001). HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide. Annals of oncology, 12(8), 1081-1089.
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55269



